Zotefoams plc (LON:ZTF - Get Free Report)'s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 290.44 ($3.94) and traded as high as GBX 340 ($4.61). Zotefoams shares last traded at GBX 309 ($4.19), with a volume of 107,014 shares traded.
Zotefoams Stock Performance
The stock has a fifty day simple moving average of GBX 272.04 and a two-hundred day simple moving average of GBX 290.44. The company has a debt-to-equity ratio of 42.07, a quick ratio of 0.67 and a current ratio of 1.30. The stock has a market capitalization of £148.62 million, a price-to-earnings ratio of 14.96, a P/E/G ratio of 0.66 and a beta of 1.40.
Zotefoams (LON:ZTF - Get Free Report) last released its quarterly earnings results on Tuesday, March 18th. The company reported GBX 25.95 ($0.35) EPS for the quarter. Zotefoams had a net margin of 7.45% and a return on equity of 8.42%.
Zotefoams Increases Dividend
The business also recently announced a dividend, which was paid on Monday, June 2nd. Investors of record on Thursday, May 1st were given a GBX 5.10 ($0.07) dividend. The ex-dividend date was Thursday, May 1st. This is a positive change from Zotefoams's previous dividend of $2.38. This represents a yield of 1.92%. Zotefoams's payout ratio is 33.89%.
About Zotefoams
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zotefoams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zotefoams wasn't on the list.
While Zotefoams currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
